Aetheramides A and B, Potent HIV-inhibitory Depsipeptides from a Myxobacterium of the New Genus "Aetherobacter"
Overview
Chemistry
Authors
Affiliations
Aetheramides are structurally distinctive cyclic peptides isolated from a novel myxobacterial genus proposed to be termed "Aetherobacter". The structures were solved by a combination of NMR analyses, quantum mechanical calculations, and chemical derivatizations. Aetheramides which contain a unique polyketide moiety and two amino acid residues potently inhibited HIV-1 infection with IC(50) values of ~0.015 μM. Furthermore aetheramides showed cytostatic activity against human colon carcinoma (HCT-116) cells with IC(50) values of 0.11 μM.
Recent advances on cyclodepsipeptides: biologically active compounds for drug research.
Liu S, Ou-Yang S, Lu Y, Guo C, Dai S, Li C Front Microbiol. 2023; 14:1276928.
PMID: 37849925 PMC: 10577210. DOI: 10.3389/fmicb.2023.1276928.
Raihan T, Rabbee M, Roy P, Choudhury S, Baek K, Azad A Front Mol Biosci. 2021; 8:732256.
PMID: 34557521 PMC: 8452873. DOI: 10.3389/fmolb.2021.732256.
Myxobacteria as a Source of New Bioactive Compounds: A Perspective Study.
Bhat M, Mishra A, Bhat M, Banday M, Bashir O, Rather I Pharmaceutics. 2021; 13(8).
PMID: 34452226 PMC: 8401837. DOI: 10.3390/pharmaceutics13081265.
Myxobacteria and their products: current trends and future perspectives in industrial applications.
Shrivastava A, Sharma R Folia Microbiol (Praha). 2021; 66(4):483-507.
PMID: 34060028 DOI: 10.1007/s12223-021-00875-z.
Okoth D, Hug J, Mandi A, Kurtan T, Garcia R, Muller R J Ind Microbiol Biotechnol. 2021; 48(3-4).
PMID: 34003283 PMC: 9113121. DOI: 10.1093/jimb/kuab029.